NAT CANCER 润色咨询

Nature Cancer

出版年份:暂无数据 年文章数:187 投稿命中率: 开通期刊会员,数据随心看

出版周期:暂无数据 自引率:暂无数据 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

投稿信息

投稿信息
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%)
自引率
暂无数据
年文章数
187
期刊官网
点击查看 (点击次数:3151)
点击查看 (点击次数:2065次)
作者需知
点击查看 (点击次数:1313次)
期刊简介
稿件收录要求

Cancer is a devastating disease that causes one in six deaths globally. A large proportion of these deaths could be prevented, but improving prevention and treatment outcomes requires accurate diagnosis, the development of effective and precise treatment modalities and a better understanding of the socioeconomic factors that affect cancer incidence, prevalence and mortality. 

Nature Cancer aims to provide a unique forum through which the cancer community will learn about the latest, most significant cancer-related advances across the life, physical, applied and social sciences. Areas of interest include fundamental, preclinical research that furthers our understanding of the mechanisms underlying tumour initiation, propagation and progression; work aiming to translate this knowledge to the clinic by focusing on new approaches for the development and delivery of diagnostic and therapeutic modalities; clinical studies informing cancer diagnosis, treatment and prevention; and new ways of understanding the global societal impact of cancer.

In addition to publishing original research, Nature Cancer will publish Comments, Reviews, News & Views, Features and Correspondence of high significance across the range of disciplines relating to cancer research.

 

Topics covered in the journal include:

 

• Cancer biology, encompassing oncogenic and tumour-suppressive mechanisms that deregulate molecular pathways and cellular processes, including tumour-initiating cells/cancer stem cells

• Cancer genetics and genomics, including functional genomics and the mechanisms underlying genome integrity, genomic instability and mutation

• Tumour evolution and heterogeneity

• Tumour–host interactions, including the tumour microenvironment (molecular, cellular, physical) and systemic effects

• Tumour immunology and immunotherapy

• Metastasis, including mechanisms of cancer cell dissemination, seeding, dormancy and growth in secondary sites

• Therapy, including design and delivery, targeted, combination and precision therapy and the study of therapy resistance

• Clinical work that informs cancer diagnosis, treatment and prevention 

• Cancer models and methodology to investigate, diagnose and treat cancer

• Systems biology, including large-scale and single-cell omics and multi-omics approaches to characterise and study cancer

• Social, ethical and policy issues relating to cancer research, prevention, diagnosis and treatment